3.4889
price down icon9.70%   -0.3711
 
loading

Finanzdaten der Precigen Inc-Aktie (PGEN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Income/Loss From Continuing Operations Before Tax
50.81%
-26.64
-54.15 -19.81 -23.97 -60.48
Income Tax Expense/Benefit, Deferred
-
- -0.089 0.012 -1.689
Income Tax Expense/Benefit
0.003
- -0.087 0.012 -1.689
Income/Loss From Continuing Operations After Tax
50.80%
-26.64
-54.15 -19.73 -23.98 -58.79
Net Income/Loss
50.80%
-26.64
-54.15 -19.73 -23.98 -58.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.87%
296.43
293.88 8.4727 275.88 252.37
Diluted Average Shares
0.87%
296.43
293.88 8.4727 275.88 252.37
Basic Earnings Per Share
50.00%
-0.09
-0.18 -0.06 -0.09 -0.23
Diluted Earnings Per Share
50.00%
-0.09
-0.18 -0.06 -0.09 -0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.35
price down icon 0.88%
$81.33
price down icon 3.26%
$28.89
price down icon 1.99%
$98.30
price down icon 1.44%
$135.49
price down icon 3.95%
biotechnology ONC
$328.74
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):